GeneTex
  • Country / Location Selection

United States (US)

SPG11 blocking peptide

Cat. No. GTX31970-PEP

Application

Neutralizing/Inhibition
Package
50 μg ($139)
PRODUCT

Summary

SPG11 peptide is used for blocking the activity of SPG11 antibody (catalog number GTX31970).

APPLICATION

Application Note

*Optimal dilutions/concentrations should be determined by the researcher.
Application Recommended Dilution
Neutralizing/Inhibition Assay dependent
Not tested in other applications.

PROPERTIES

Form

Liquid

Buffer

PBS, 0.1% BSA

Preservative

0.02% Sodium azide

Storage

Store as concentrated solution. Aliquot and store at -20ºC or below. Avoid freeze-thaw cycles.

Concentration

200 μg/ml (Please refer to the vial label for the specific concentration.)

Conjugation

Unconjugated

Note

For laboratory research use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.

Purchasers shall not, and agree not to enable third parties to, analyze, copy, reverse engineer or otherwise attempt to determine the structure or sequence of the product.

TARGET

Synonyms

Spg11, Spatacsin Vesicle Trafficking Associated , Als5 , Cmt2X , Kiaa1840 , Spg11

Background

The protein encoded by this gene is a potential transmembrane protein that is phosphorylated upon DNA damage. Defects in this gene are a cause of spastic paraplegia type 11 (SPG11). Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2009]

Research Area

REFERENCE

There are currently no references for SPG11 blocking peptide (GTX31970-PEP). Be the first to share your publications with this product.

REVIEW

There are currently no reviews for SPG11 blocking peptide (GTX31970-PEP). Be the first to share your experience with this product.
SDS
PBS.pdf
Sodium Azide.pdf
Package List Price ($)
$ 139